Breast Cancer Information, News and Updates

After more than 8 years of follow-up, older women taking the newerdrug fared better, study finds

More: continued here

Few men understand the danger from BRCA1/2, researchers say

More: continued here

Breast cancer patients whose tumors test positive for the proteinHER-2 and test negative for hormone receptors have a high risk oftreatment failure after chemotherapy — and the most common site ofcancer recurrence after treatment failure is the brain, Mayo Clinicresearchers reported at the San Antonio Breast Cancer Symposium.

More: continued here

For a subset of cancer types, treatment needs to be much tougherthan is typically done, study finds

More: continued here

Genomic Health Inc said on Thursday its genetic test can helppredict when chemotherapy is likely to benefit women with breastcancer that has spread to the lymph nodes.

More: continued here

The long-term findings of a large, multicenter study show thatbreast cancer survival is significantly improved and side effectsare significantly less severe with Taxotere (also called docetaxel)than with Adriamycin (also called doxorubicin).

More: continued here

Swelling in arms or legs can come after infection or cancertherapy, researchers note

More: continued here

A combination drug treatment that includes Tykerb, know genericallyas lapatinib, appears to be able to fight breast cancer that hasspread to the brain, GlaxoSmithKline Plc announced Sunday.

More: continued here

After approximately 8 years, postmenopausal women withhormone-sensitive breast cancer who received (Arimidex),generically known as anastrazole, had a lower risk of recurrencethan women taking tamoxifen, investigators reported at the annualmeeting of the San Antonio Breast Cancer Symposium.

More: continued here

Review of studies finds regimen popular in 1980s doesn’t reallylengthen life

More: continued here